Standout Papers
- Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (2020)
- Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial (2023)
Immediate Impact
1 by Nobel laureates 4 from Science/Nature 61 standout
Citing Papers
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma
2023 Standout
A neutrophil response linked to tumor control in immunotherapy
2023 Standout
Works of Giuseppe Procopio being referenced
The Evaluation of Response to Immunotherapy in Metastatic Renal Cell Carcinoma: Open Challenges in the Clinical Practice
2019
Inflammatory indexes strongly predict clinical outcome in patients (pts) with metastatic renal cell cancer (mRCC) treated with nivolumab: results from the Italian expanded access program (EAP)
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Giuseppe Procopio | 2967 | 2618 | 1201 | 1488 | 353 | 5.0k | |
| Haruyasu Murakami | 3640 | 3763 | 889 | 1361 | 304 | 6.0k | |
| Tomoyuki Yokose | 3266 | 2603 | 808 | 1185 | 270 | 6.5k | |
| Seiji Niho | 2902 | 3127 | 540 | 1093 | 213 | 4.9k | |
| Kiyotaka Yoh | 2533 | 2911 | 726 | 1319 | 269 | 4.5k | |
| Maria Di Bartolomeo | 2316 | 4586 | 834 | 882 | 247 | 6.3k | |
| Anna S. Berghoff | 3114 | 3702 | 893 | 1521 | 290 | 7.1k | |
| Heine H. Hansen | 2539 | 4110 | 693 | 1527 | 197 | 6.5k | |
| Philip Bonomi | 4349 | 4803 | 961 | 2075 | 240 | 7.8k | |
| Hagen F. Kennecke | 1399 | 3534 | 1847 | 1320 | 154 | 5.4k | |
| Takashi Seto | 6507 | 5971 | 1160 | 2199 | 362 | 8.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...